ARTICLE | Clinical News
QLT091001: Phase Ib started
December 21, 2009 8:00 AM UTC
QLT began an open-label, Canadian Phase Ib trial to evaluate oral QLT091001 given once daily for 7 days in 8 pediatric patients with inherited deficiency of retinal pigment epithelium protein 65 (RPE6...